Physical Activity Trial for Multiple Myeloma Quality of Life
ClinicalTrials.gov Studies
Summary
This NIH-registered clinical trial (NCT07547007) will evaluate a 6-month, individualized, hybrid adapted physical activity program on quality of life in patients treated for multiple myeloma. Participants are randomised to a control group receiving physical activity advice only or an interventional group receiving a combination of remote home sessions and in-person hospital sessions. The trial will measure effects on effort tolerance, pain, muscular mass, osteolytic lesions, treatment tolerance, and treatment response.
“The goal of this clinical trial is to evaluate the effect of a long-term, individualized, hybrid adapted physical activity program on the quality of life of patients with multiple myeloma.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
The document registers a new clinical trial (NCT07547007) on ClinicalTrials.gov, describing a randomised controlled study evaluating the benefits of a 6-month individualized hybrid adapted physical activity program for multiple myeloma patients. Participants are assigned to either a control group receiving standard physical activity advice or an interventional group receiving combined home-based remote and in-person hospital sessions.
For clinical operations teams and trial sponsors, this registry entry indicates an active clinical investigation into supportive care interventions for myeloma patients. Researchers conducting similar oncology supportive care studies or those recruiting myeloma patients should note this competing trial in their site feasibility assessments and protocol design considerations.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Benefits of a 6-month, Individualized, Hybrid, "Real-life" Adapted Physical Activity Program on the Quality of Life of Patients Treated for Multiple Myeloma
N/A NCT07547007 Kind: NA Apr 23, 2026
Abstract
The goal of this clinical trial is to evaluate the effect of a long-term, individualized, hybrid adapted physical activity program on the quality of life of patients with multiple myeloma. The main question it aims to answer are :
Does this logn term, individualized and hybrid adapted physical activity program improve quality of life in multiple myeloma patient ? What are the effects of this program on effort tolerance, pain, muscular mass, osteolytic lesions, tolerance to treatment, response to treatment? If there is a comparison group: Researchers will compare [arm information] to see if [insert effects].
Participants will be randomised in 2 groups.
- control group: patients will receive only advices about physical activities benefit
- interventional group: This group will be offered a program of adapted physical activities mixing sessions at home (remote) and sessions at the hospital (in person).
Conditions: Multiple Myeloma (MM)
Interventions: Adapted physical activity
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.